Dauntless
Dauntless is a free-to-play action game developed by Phoenix Labs and published by Epic Games. The game was initially released in May 2019 and is available on multiple platforms including Microsoft Windows, PlayStation 4, Xbox One, and Nintendo Switch. Dauntless is set in a fantasy world where players take on the role of Slayers, brave warriors who hunt massive monsters known as Behemoths to prevent them from consuming the world's remaining resources.
Gameplay[edit | edit source]
In Dauntless, players collaborate in small teams to track and hunt Behemoths, using a variety of weapons and tactics. The game features a cooperative multiplayer mode where players can join forces to take down larger and more challenging Behemoths. Each Behemoth has its own set of abilities and behaviors, requiring players to develop strategic plans and coordinate their efforts effectively.
Players can choose from several different weapon classes, including swords, axes, hammers, and more exotic options like the war pike and chain blades. Each weapon type offers a unique playstyle and set of moves, allowing players to tailor their combat experience to their preferences.
Development and Release[edit | edit source]
Dauntless was developed by Phoenix Labs, a studio founded by former employees of Riot Games and other major gaming companies. The game was initially announced in 2016 and entered early access in 2018 before its official release in 2019. Dauntless utilizes the Unreal Engine 4, which enables high-quality graphics and dynamic weather systems that influence gameplay.
Reception[edit | edit source]
Dauntless has been generally well-received by both critics and players. The game is praised for its engaging multiplayer experience, accessible gameplay mechanics, and the developers' commitment to regular updates and expansions. However, some criticism has been directed at its repetitive nature and the grind required to progress at later stages.
Community and Updates[edit | edit source]
Phoenix Labs has been active in maintaining a strong community around Dauntless, with regular updates that introduce new Behemoths, weapons, and seasonal events. The developers also engage with players through forums and social media to gather feedback and ensure the game continues to evolve in ways that satisfy its player base.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD